What is the <u>mainstay treatment</u> of&nbsp;<b>uveitic macular edema (UME)</b>?<br>{{c1::Sub-Tenon triamcinolone acetonide}}<br><br>If <u>UME persists</u>?<br>{{c2::Intravitreal steroid/implant::2}}<br><br>If <u>recalcitrant UME</u>?<br>{{c3::Systemic interferon therapy}}<br><br>If associated VMT?<br>{{c4::Pars plana vitrectomy}}<br style="">

Dosages:<br>Sub-Tenon 20–40 mg of triamcinolone acetonide<br>2–4 mg of intravitreal triamcinolone or corticosteroids implants<br><br>Topical NSAIDs for pseudophakic UME<br>Oral acetazolamide 500 mg once or BD if inflammation is well controlled<br>anti-VEGF may be effective for short-duration and needs repeated injections<br>Intravitreal methotrexate (400 μg/0.1 mL) under investigation<br>Implants: Retisert (Bausch + Lomb), Ozurdex (Allergan), and Yutiq (EyePoint Pharmaceuticals)